ArticleJournal of radiosurgery and SBRT2022
Overview of the current role of stereotactic body radiotherapy in the treatment of unfavorable intermediate- and high-risk prostate cancer.
Maris Mezeckis et al.PubMed ↗Full text ↗
No numbers read from the abstract.